European journal of heart failure
Journal
Overview
publication venue for
-
Non-invasive prediction of pulmonary vascular disease-related exercise intolerance and survival in non-group 1 pulmonary hypertension.
2024
-
Pulmonary hypertension across the spectrum of left heart and lung disease.
2024
-
On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF.
2024
-
Association between serum albumin and outcomes in heart failure and secondary mitral regurgitation: the COAPT trial..
25.
2023
-
Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort..
24.
2022
-
Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 1: overview and the central role for catecholamines and sympathetic nervous system..
24.
2022
-
Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications..
24.
2021
-
Impact of hospital transfer to hubs on outcomes of cardiogenic shock in the real world..
23.
2021
-
Association of preoperative infections, nasal Staphylococcus aureus colonization and gut microbiota with left ventricular assist device outcomes..
23.
2021
-
Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants..
23.
2021
-
Impact of recent heart failure hospitalization on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the PARTNER 2 trial and registries..
22.
2020
-
A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics..
18.
2016
-
Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction..
18.
2015
-
Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study..
16.
2014
-
Spinal cord stimulation is safe and feasible in patients with advanced heart failure: early clinical experience..
16.
2014
-
The effect of thyroid function on clinical outcome in patients with heart failure..
16.
2013
-
A mouse model reveals an important role for catecholamine-induced lipotoxicity in the pathogenesis of stress-induced cardiomyopathy..
15.
2012
-
Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation..
14.
2012
-
Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis..
14.
2012
-
Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study..
13.
2011
-
Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices..
13.
2010
-
Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme..
12.
2010
-
Myostatin activation in patients with advanced heart failure and after mechanical unloading..
12.
2010
-
Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results..
11.
2009
-
Echocardiographic ejection fraction in patients with acute heart failure: correlations with hemodynamic, clinical, and neurohormonal measures and short-term outcome..
7.
2005
-
The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure..
6.
2004
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)